The longer the world does not know what Bisantrene is the better it is for us establishing first mover advantage in as many opportunities as possible.
I think a significant amount of critical thought and patience is required to realize the best play with the knowledge we have. Cancer is very hard to treat, but we have a drug that has worked in 22 of them. Read it again!
It 100% is not to be all guns blazing on one indication, albeit a large one. The best outcome for us is a bidding war and that happens with a lot of data for a lot of cancers and drug combinations with cancer therapies owned by many different pharmaceutical companies.
The longer the world does not know what Bisantrene is the better...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.64 |
Change
-0.015(0.91%) |
Mkt cap ! $281.1M | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.66 | $1.64 | $54.86K | 33.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17732 | $1.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.64 | 2600 | 1 |
View Market Depth
| Last trade - 12.44pm 29/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |